← LeaderboardsInvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
The Geneva Foundation
$248,877,424
Total funding
236
Grants
Funding over time
peak $28.8M · FY2008–25$50M$37.5M$25M$12.5M$0
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
DOD$248,877,424 · 236
By mechanism
—$248,877,424 · 236
Investigators at The Geneva Foundation
InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).
Rising Stars
First grant in the last 5 yrs
Not enough data
Emerging Leaders
6–10 yrs in
Not enough data
All-Time
Most funded here, all years
Not enough data
Largest grants
TREATMENT OF TRAUMATIC BRAIN INJURY USING NNZ-2566: CLINICAL TRIALS$9,195,708
· FY2008 · Department of Defense
SYSTEMS BIOLOGY FOR MILITARY PROTECTION, PERFORMANCE, AND READINESS$6,996,023
· FY2013 · Department of the Army
PRECISIE RTD TRIAL: PRECISION WITH RETURN-TO-DUTY DECISIONS IN THE MILITARY$6,663,794
· FY2024 · Defense Health Agency
IMPROVED FIELD MANAGEMENT AND SAFE GROUND TRANSPORT OF PATIENTS WITH HEAD AND SPINE INJURIES.$6,260,214
· FY2013 · Department of the Army
BLAST-INDUCED ACCELERATION IN A SHOCK TUBE: DISTINGUISHING PRIMARY AND TERTIARY BLAST INJURY$6,170,384
· FY2012 · Department of Defense
DEEP CHARACTERIZATION OF ROUSETTUS AEGYPTIACUS IMMUNE SYSTEM: USE OF BATS / NONHUMAN PRIMATES TO COMPARE IMMUNE RESPONSE DURING SYMPTOMATIC / SYMPTOM$5,331,196
· FY2014 · Defense Threat Reduction Agency
STEM CELLS THERAPEUTICS FOR MILITARY RELEVANT BRIAN INJURY USING AMNOIN-DERIVED MULTIPOTENT PROGENITOR (AMP) CELLS$5,172,544
· FY2008 · Department of Defense
HEPARIN-FREE EXTRACORPOREAL LIFE SUPPORT FOR POINT-OF-NEED TREATMENT OF SINGLE AND MULTIORGAN FAILURE$4,923,620
· FY2019 · Defense Health Agency
BRAIN INJURY BIOMARKERS AND BEHAVIORAL CHARACTERIZATION OF MTBI IN SOLDIERS FOLLOWING REPEATED, LOW-LEVEL BLAST EXPOSURE$4,856,091
· FY2009 · Department of Defense
DEVELOPMENT OF PATIENT-MATCHED SEGMENTAL DEFECT IMPLANT SYSTEM WITH MECHANOBIOLOGIC ACTIVATION AND ANTIMICROBIAL COATING FOR TREATMENT OF SEVERE FRACTURES$4,817,413
· FY2025 · Defense Health Agency
NEAR-INFRARED SPECTROSCOPY TO REDUCE THE PROPHYLACTIC FASCIOTOMIES FOR AND MISSED CASES OF ACUTE COMPARTMENT SYNDROME IN SOLDERS INJURED IN OEF/OIF$4,800,045
· FY2009 · Department of the Army
OMICS CHARACTERIZATION OF COMBAT-RELATED PTSD: EARLY ONSET AND FEMALE STUDIES$4,203,427
· FY2018 · Department of the Army
DIAGNOSIS AND TREATMENT OF TBI AND POLYTRAUMA DURING GROUND AND HIGH ALTITUDE EVACUATION USING LIQUID BIOPSY AND EXTRACORPOREAL LIFE SUPPORT$4,123,449
· FY2019 · Defense Health Agency
EVALUATION OF ROLE 2 (R2) MEDICAL RESOURCES IN THE AFGHANISTAN COMBAT THEATER: PAST, PRESENT AND FUTURE$3,540,354
· FY2015 · Department of the Army
HEPARIN-FREE MINIMAL INVASIVE EXTRACORPOREAL LIFE SUPPORT TREATMENT OF ACUTE LUNG INJURY$3,473,220
· FY2018 · Defense Health Agency
DEVELOPMENT AND VALIDATION OF A NOVEL IMMUNOTHERAPY FOR TRAUMATIC HEMORRHAGE$3,164,353
· FY2020 · Defense Health Agency
EFFECTS OF ACOUSTIC IMPULSES ON THE MIDDLE EAR$3,075,864
· FY2014 · Department of the Army
INHALATION OF OXYGEN AEARLY AFTER INJURY$2,993,950
· FY2009 · Department of Defense
MOUSE MODELS OF POST TRAUMATIC STRESS SYNDROME$2,947,292
· FY2009 · Department of Defense
DEVELOP A PROTOTYPE HEALTH RECORD APPLICATION (PHR-A)THAT CAPTURES INFORMATION ABOUT DAILY LIVING IMPORTANT FOR DIABETES$2,922,832
· FY2009 · Department of Defense